Cargando…

Orodispersible Film (ODF) Platform Based on Maltodextrin for Therapeutical Applications

Orodispersible film (ODF) is a new dosage form that disperses rapidly in the mouth without water or swallowing. The main ingredient of an ODF is a polymer that can be both of natural or synthetic origin. Maltodextrin is a natural polymer, mainly used in pharmaceutical and nutraceutical fields. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Cupone, Irma E., Sansone, Andrea, Marra, Fabio, Giori, Andrea M., Jannini, Emmanuele A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607423/
https://www.ncbi.nlm.nih.gov/pubmed/36297447
http://dx.doi.org/10.3390/pharmaceutics14102011
_version_ 1784818540212125696
author Cupone, Irma E.
Sansone, Andrea
Marra, Fabio
Giori, Andrea M.
Jannini, Emmanuele A.
author_facet Cupone, Irma E.
Sansone, Andrea
Marra, Fabio
Giori, Andrea M.
Jannini, Emmanuele A.
author_sort Cupone, Irma E.
collection PubMed
description Orodispersible film (ODF) is a new dosage form that disperses rapidly in the mouth without water or swallowing. The main ingredient of an ODF is a polymer that can be both of natural or synthetic origin. Maltodextrin is a natural polymer, mainly used in pharmaceutical and nutraceutical fields. This review aims to examine the literature regarding ODFs based on maltodextrin as the platform for developing new products for therapeutical application. ODFs based on maltodextrin contain plasticizers that enhance their flexibility and reduce their brittleness. Surfactants; fillers, such as homopolymer and copolymer of vinylacetate; flavour and sweetener were introduced to improve ODF characteristics. Both water-soluble and insoluble APIs were introduced up to 100 mg per dosage unit. The solvent casting method and hot-melt extrusion are the most useful techniques for preparing ODFs. In particular, the solvent casting method allows manufacturing processes to be developed from a lab scale to an industrial scale. ODFs based on maltodextrin are characterized in terms of mechanical properties, dissolution rate, taste and stability. ODFs made of maltodextrin, developed by IBSA, were tested in vivo to evaluate their bioequivalence and efficacy and were demonstrated to be a valid alternative to the marketed oral dosage forms.
format Online
Article
Text
id pubmed-9607423
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96074232022-10-28 Orodispersible Film (ODF) Platform Based on Maltodextrin for Therapeutical Applications Cupone, Irma E. Sansone, Andrea Marra, Fabio Giori, Andrea M. Jannini, Emmanuele A. Pharmaceutics Review Orodispersible film (ODF) is a new dosage form that disperses rapidly in the mouth without water or swallowing. The main ingredient of an ODF is a polymer that can be both of natural or synthetic origin. Maltodextrin is a natural polymer, mainly used in pharmaceutical and nutraceutical fields. This review aims to examine the literature regarding ODFs based on maltodextrin as the platform for developing new products for therapeutical application. ODFs based on maltodextrin contain plasticizers that enhance their flexibility and reduce their brittleness. Surfactants; fillers, such as homopolymer and copolymer of vinylacetate; flavour and sweetener were introduced to improve ODF characteristics. Both water-soluble and insoluble APIs were introduced up to 100 mg per dosage unit. The solvent casting method and hot-melt extrusion are the most useful techniques for preparing ODFs. In particular, the solvent casting method allows manufacturing processes to be developed from a lab scale to an industrial scale. ODFs based on maltodextrin are characterized in terms of mechanical properties, dissolution rate, taste and stability. ODFs made of maltodextrin, developed by IBSA, were tested in vivo to evaluate their bioequivalence and efficacy and were demonstrated to be a valid alternative to the marketed oral dosage forms. MDPI 2022-09-22 /pmc/articles/PMC9607423/ /pubmed/36297447 http://dx.doi.org/10.3390/pharmaceutics14102011 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Cupone, Irma E.
Sansone, Andrea
Marra, Fabio
Giori, Andrea M.
Jannini, Emmanuele A.
Orodispersible Film (ODF) Platform Based on Maltodextrin for Therapeutical Applications
title Orodispersible Film (ODF) Platform Based on Maltodextrin for Therapeutical Applications
title_full Orodispersible Film (ODF) Platform Based on Maltodextrin for Therapeutical Applications
title_fullStr Orodispersible Film (ODF) Platform Based on Maltodextrin for Therapeutical Applications
title_full_unstemmed Orodispersible Film (ODF) Platform Based on Maltodextrin for Therapeutical Applications
title_short Orodispersible Film (ODF) Platform Based on Maltodextrin for Therapeutical Applications
title_sort orodispersible film (odf) platform based on maltodextrin for therapeutical applications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607423/
https://www.ncbi.nlm.nih.gov/pubmed/36297447
http://dx.doi.org/10.3390/pharmaceutics14102011
work_keys_str_mv AT cuponeirmae orodispersiblefilmodfplatformbasedonmaltodextrinfortherapeuticalapplications
AT sansoneandrea orodispersiblefilmodfplatformbasedonmaltodextrinfortherapeuticalapplications
AT marrafabio orodispersiblefilmodfplatformbasedonmaltodextrinfortherapeuticalapplications
AT gioriandream orodispersiblefilmodfplatformbasedonmaltodextrinfortherapeuticalapplications
AT janniniemmanuelea orodispersiblefilmodfplatformbasedonmaltodextrinfortherapeuticalapplications